Literature DB >> 12598425

The ACh-induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells.

Luca Mazzetti1, Sergio Franchi-Micheli, Silvia Nistri, Silvia Quattrone, Ruggero Simone, Mario Ciuffi, Lucilla Zilletti, Paola Failli.   

Abstract

1. Our previously published data indicate that an endogenously produced 5-lipoxygenase metabolite can strongly contract isolated endothelium-preserved rat aortic strips when cyclo-oxygenase isoenzymes are inhibited. Therefore, we decided to investigate if cysteinyl-containing leukotrienes (Cys Lts) are involved in this endothelium-dependent contraction. 2. The isometric contraction of endothelium-preserved rat aortic strips was recorded in preparations preincubated with 5 microM indomethacin and precontracted with phenylephrine, adjusting resting tension at 0.7 g. Acetylcholine (ACh) contracted control strips. Montelukast and MK-571, selective type 1 Cys Lts receptor (Cys Lt(1)) antagonists and the Cys Lt(1)/Cys Lt(2) (type 2 Cys Lts receptor) antagonist BAYu9773 dose-dependently prevented ACh-induced contraction, their IC(50)s being 2.2, 3.1 and 7.9 nM respectively. The leukotriene B4 receptor antagonist U75302 was far less potent (IC(50) 1.5 microM). 3. In rat aorta smooth muscle cells (RASMs), Western blot analysis showed the presence of Cys Lt(1) and Cys Lt(2) receptors, the Cys Lt(1) receptor being predominantly expressed. 4. In fura-2 loaded RASMs, LTD4 (0.01-100 nM) and LTC4 (200-800 nM) dose-dependently increased intracellular calcium concentration ([Ca(2+)](i)). Montelukast (1-100 nM) reduced LTD4-induced [Ca(2+)](i) increase, its IC(50) being approximately 10 nM. BAY u9773 exhibited significantly low effectiveness. 5. LTD4 (10 nM) induced a redistribution of smooth muscle actin fibres throughout the cytoplasm as visualized by confocal microscopy. 6. In conclusion, Cys Lt(1) activation by endogenously produced Cys Lts, can contract rat aortas, while Cys Lt(2) only marginally influences aortic tone. Intracellularly, this effect is mediated by an increase in [Ca(2+)](i). Therefore, Cys Lts, by inducing vascular contraction, can contribute to systemic hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598425      PMCID: PMC1573698          DOI: 10.1038/sj.bjp.0705087

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

Review 1.  The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle.

Authors:  Ian McFadzean; Alan Gibson
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.

Authors:  H P Nothacker; Z Wang; Y Zhu; R K Reinscheid; S H Lin; O Civelli
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Mechanical stretch reveals different components of endothelial-mediated vascular tone in rat aortic strips.

Authors:  S Franchi-Micheli; P Failli; L Mazzetti; D Bani; M Ciuffi; L Zilletti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness.

Authors:  A Sala; G Rossoni; F Berti; C Buccellati; A Bonazzi; J Maclouf; G Folco
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

5.  Characterization of the human cysteinyl leukotriene 2 receptor.

Authors:  C E Heise; B F O'Dowd; D J Figueroa; N Sawyer; T Nguyen; D S Im; R Stocco; J N Bellefeuille; M Abramovitz; R Cheng; D L Williams; Z Zeng; Q Liu; L Ma; M K Clements; N Coulombe; Y Liu; C P Austin; S R George; G P O'Neill; K M Metters; K R Lynch; J F Evans
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

6.  The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.

Authors:  J Takasaki; M Kamohara; M Matsumoto; T Saito; T Sugimoto; T Ohishi; H Ishii; T Ota; T Nishikawa; Y Kawai; Y Masuho; T Isogai; Y Suzuki; S Sugano; K Furuichi
Journal:  Biochem Biophys Res Commun       Date:  2000-08-02       Impact factor: 3.575

7.  Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats.

Authors:  F Stanke-Labesque; P Devillier; S Veitl; F Caron; J L Cracowski; G Bessard
Journal:  Cardiovasc Res       Date:  2001-01       Impact factor: 10.787

8.  Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

Authors:  H M Sarau; R S Ames; J Chambers; C Ellis; N Elshourbagy; J J Foley; D B Schmidt; R M Muccitelli; O Jenkins; P R Murdock; N C Herrity; W Halsey; G Sathe; A I Muir; P Nuthulaganti; G M Dytko; P T Buckley; S Wilson; D J Bergsma; D W Hay
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

9.  Increased leukotriene A(4) hydrolase expression in the heart of angiotensin II-induced hypertensive rat.

Authors:  N Ishizaka; A Nakao; N Ohishi; M Suzuki; T Aizawa; J Taguchi; R Nagai; T Shimizu; M Ohno
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

10.  Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.

Authors:  V Martin; N Sawyer; R Stocco; D Unett; M R Lerner; M Abramovitz; C D Funk
Journal:  Biochem Pharmacol       Date:  2001-11-01       Impact factor: 5.858

View more
  5 in total

Review 1.  Arachidonic acid and ion channels: an update.

Authors:  H Meves
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

2.  The mechanism underlying the contractile effect of a chemotactic peptide, formyl-Met-Leu-Phe on the guinea-pig Taenia coli.

Authors:  Hiroshi Kawata; Katsuya Hirano; Junji Nishimura; Chiharu Kubo; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated rats.

Authors:  Françoise Stanke-Labesque; Gaëlle Hardy; Françoise Caron; Jean-Luc Cracowski; Germain Bessard
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

Review 4.  Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.

Authors:  Francesca Colazzo; Paolo Gelosa; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-08-28       Impact factor: 4.711

5.  Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats.

Authors:  Paola Failli; Chiara Alfarano; Sergio Franchi-Micheli; Edoardo Mannucci; Elisabetta Cerbai; Alessandro Mugelli; Laura Raimondi
Journal:  Cardiovasc Diabetol       Date:  2009-06-22       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.